 |
Minimale Einzahlung $50 Exklusive Aktion |
Unser Ergebnis |
0% Kommission |
Are you looking to buy DexCom stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:DXCM! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about DexCom stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient’s mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products; a collaboration with Companion Medical, Inc.; and a development and commercialization agreement with Tandem Diabetes Care, Inc. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Durchschnittliches Volumen
943,679 shs
MARKTKAPPE
$39.22 billion
Börse
NASDAQ
Kaufen Sie diese Aktie!
|
NAME
|
TICKER
|
INDUSTRIE
|
SECTOR
|
VOLUME
|
KAUFEN SIE DIESE AKTIE JETZT
|
|---|---|---|---|---|---|
|
NASDAQ:DXCM
|
Chirurgische und medizinische Instrumente
|
Medizinisch
|
6,266 shs
|
Below is a quick guide on how to buy NASDAQ:DXCM stocks safe, fast and around the world in less than five minutes.
Schritt 1: Eröffnen Sie ein Konto bei eToro – eToro is the best broker to buy DexCom shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Schritt 2: Laden Sie Ihre ID hoch - Gemäß den KYC-Vorschriften wird eToro Sie bitten, eine Kopie Ihres Reisepasses oder Führerscheins hochzuladen.
Schritt 3: Geld einzahlen - Zahlen Sie etwas Geld auf Ihr neu eingerichtetes eToro Konto ein. Sie können zwischen Banküberweisung, E-Wallet, Debit-/Kreditkarte oder Paypal wählen.
Schritt 4: Buy DexCom – Search for “”NASDAQ:DXCM”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought DexCom stocks with 0% commission!.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
18 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for DexCom in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” DexCom stock.
Wall Street analysts have given DexCom a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but DexCom wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
2 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
3 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:DXCM stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy DexCom stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy DexCom stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Da es sich bei eToro um eine regulierte Plattform handelt, müssen Sie das KYC-Verfahren abschließen. Dies ist gängige Praxis und dauert nur ein paar Minuten. Sie müssen einen Lichtbildausweis (Reisepass, Führerschein) und einen Adressnachweis (Stromrechnung, Kontoauszug) vorlegen.
Sobald Sie sich angemeldet und Ihr Konto verifiziert haben, müssen Sie Geld einzahlen. eToro akzeptiert Kredit-/Debitkarten, Banküberweisungen und auch E-Wallets. Was auch immer Sie bevorzugen, es wird etwas für Sie dabei sein.
Now that you’ve funded your eToro account, just type “NASDAQ:DXCM stocks" in die Suchleiste am oberen Rand des Bildschirms ein und drücken Sie auf "Handeln".
All that’s left is to buy some NASDAQ:DXCM stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:DXCM is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy DexCom stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
DexCom is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for DexCom.
DexCom will be holding an earnings conference call on Thursday, February 11th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
DexCom, Inc. (NASDAQ:DXCM) released its quarterly earnings results on Tuesday, October, 27th. The medical device company reported $0.94 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.30. The medical device company earned $500.90 million during the quarter, compared to analysts’ expectations of $477.22 million. DexCom had a net margin of 12.69% and a trailing twelve-month return on equity of 27.29%.
View DexCom’s earnings history.
DexCom’s stock was trading at $252.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DXCM stock has increased by 62.4% and is now trading at $409.99.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:DXCM stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mehr als 95% der Kundengelder werden offline, in kalten Lagern, aufbewahrt, was für jeden Broker, der Ihr Vermögen verwaltet, entscheidend ist. Unabhängig davon, wie sicher eine Plattform sein soll, empfehlen wir die Verwendung von 2FA, um eine zusätzliche Sicherheitsebene für Ihr Konto zu schaffen.
eToro bietet Nutzern eine Reihe von Funktionen, um so schnell wie möglich mit dem Investieren zu beginnen. Es gibt eine relativ einzigartige Funktion namens Copy Trading, mit der Sie ein passives Einkommen erzielen können, indem Sie erfahrene Händler spiegeln. So können Sie schnell Gewinne erzielen und erhalten ein besseres Verständnis für die Strategien, die von Profis verwendet werden. Außerdem können Sie bei eToro in verwaltete Portfolios investieren. Ein verwaltetes Portfolio besteht aus einer Vielzahl ähnlicher Vermögenswerte, die in Gruppen zusammengefasst sind. Wenn Sie bereits über Handelserfahrung verfügen, können Sie auch in andere Märkte als Aktien investieren, da eToro den Handel mit ETFs, Rohstoffen, Kryptowährungen und Indizes ermöglicht. Wenn Sie bereits außerhalb des Aktienmarktes investieren, kann dies sehr nützlich sein, da Sie so alle Ihre Investitionen an einem einzigen Ort verwalten können.
DexCom updated its fourth quarter 2020 Pre-Market earnings guidance on Monday, January, 11th. The company provided EPS guidance of for the period. The company issued revenue guidance of $567 million, compared to the consensus revenue estimate of $550.73 million.
18 equities research analysts have issued 1-year target prices for DexCom’s stock. Their forecasts range from $240.00 to $500.00. On average, they expect DexCom’s share price to reach $419.18 in the next year. This suggests a possible upside of 2.2% from the stock’s current price.
View analysts’ price targets for DexCom or view top-rated stocks among Wall Street analysts.
CFDs sind komplexe Instrumente und bergen aufgrund der Hebelwirkung ein hohes Risiko, schnell Geld zu verlieren. 68% der Konten von Kleinanlegern verlieren Geld beim Handel mit CFDs bei diesem Anbieter. Sie sollten sich überlegen, ob Sie verstehen, wie CFDs funktionieren und ob Sie das hohe Risiko, Ihr Geld zu verlieren, eingehen können.
DexCom saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 3,490,000 shares, an increase of 19.9% from the December 15th total of 2,910,000 shares. Based on an average trading volume of 1,120,000 shares, the days-to-cover ratio is currently 3.1 days.
View DexCom’s Short Interest.
DexCom’s management team includes the following people:
Mr. Kevin R. Sayer, Exec. Chairman, CEO & Pres (Age 63, Pay $2.09M)
Mr. Quentin S. Blackford, CFO & COO (Age 42, Pay $1.17M)
Mr. Steven R. Pacelli, Exec. VP of Strategy & Corp. Devel. (Age 49, Pay $873.62k)
Mr. Andrew K. Balo, Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel. (Age 73, Pay $875.97k)
Mr. Jereme Sylvain, Sr. VP of Fin., Chief Accounting Officer & Corp. Controller (Age 41)
Mr. Jacob Steven Leach, Exec. VP & CTO (Age 43)
Mr. Sean Christensen, Sr. Investor Relations Mang.
Mr. Patrick Michael Murphy, Exec. VP & Chief Legal Officer (Age 42)
Chad Patterson, Sr. VP of Global Marketing
Ms. Sadie M. Stern, Exec. VP & Chief HR Officer (Age 46)
347 employees have rated DexCom CEO Kevin Sayer on Glassdoor.com. Kevin Sayer has an approval rating of 88% among DexCom’s employees.
Some companies that are related to DexCom include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Baxter International (BAX), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Varian Medical Systems (VAR) and STERIS (STE).
View all of DXCM’s competitors.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
Based on aggregate information from Reportlab watchlists, some companies that other DexCom investors own include NVIDIA (NVDA), PayPal (PYPL), Alibaba Group (BABA), Netflix (NFLX), Tesla (TSLA), salesforce.com (CRM), ServiceNow (NOW), The Walt Disney (DIS), The Trade Desk (TTD) and Shopify (SHOP).
DexCom trades on the NASDAQ under the ticker symbol “DXCM.”
DexCom’s stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Jennison Associates LLC (2.07%), Sumitomo Mitsui Trust Holdings Inc. (0.46%), Swiss National Bank (0.38%), Victory Capital Management Inc. (0.28%), Frontier Capital Management Co. LLC (0.24%) and California Public Employees Retirement System (0.23%). Company insiders that own DexCom stock include Andrew K Balo, Barbara Kahn, Bridgette P Heller, Donald Abbey, Heather S Ace, Jacob Steven Leach, Jeffrey Moy, Jereme M Sylvain, Kevin R Sayer, Mark G Foletta, Nicholas Augustinos, Patrick Michael Murphy, Quentin S Blackford, Richard Alexander Collins, Richard Doubleday, Shelly Ramasamy Selvaraj, Steven R Altman and Steven Robert Pacelli.
View institutional ownership trends for DexCom.
DXCM stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Sumitomo Mitsui Trust Holdings Inc., Robeco Institutional Asset Management B.V., First Trust Advisors LP, Catalyst Capital Advisors LLC, Daiwa Securities Group Inc., Janney Montgomery Scott LLC, and Aperio Group LLC. Company insiders that have sold DexCom company stock in the last year include Andrew K Balo, Barbara Kahn, Bridgette P Heller, Donald Abbey, Heather S Ace, Jacob Steven Leach, Jeffrey Moy, Jereme M Sylvain, Kevin R Sayer, Mark G Foletta, Nicholas Augustinos, Patrick Michael Murphy, Quentin S Blackford, Richard Alexander Collins, Richard Doubleday, Shelly Ramasamy Selvaraj, Steven R Altman, and Steven Robert Pacelli.
View insider buying and selling activity for DexCom or view top insider-selling stocks.
DXCM stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Strs Ohio, C WorldWide Group Holding A S, Scout Investments Inc., Fisher Asset Management LLC, Russell Investments Group Ltd., Assenagon Asset Management S.A., and Peregrine Capital Management LLC.
View insider buying and selling activity for DexCom or or view top insider-buying stocks.
Shares of DXCM can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interaktive Makler Bewertung, eToro Überprüfung, DEGiro Rückblick, AvaTrade Bewertung, IG Markets Rückblick, IC Märkte Rückblick, CMC Markets Rückblick, Admiral Markets Rückblick und viele mehr. Lesen Sie eine der Bewertungen, um alles über den Broker zu erfahren, und beginnen Sie jetzt mit dem Kauf von Aktien.
Wir von Reportlab.org möchten sicherstellen, dass Sie alle wichtigen Informationen über Aktien kaufen. Wir bieten Ihnen die besten Leitfäden zum Thema Börse mit persönlichen Bewertungen, Hintergrundinformationen, Plattformbewertungen, Anleitungen und mehr. Möchten Sie weitere Informationen erhalten? Dann schauen Sie sich die OTC-Aktien, NASDAQ-Aktien, NYSE-Aktien, LON-Aktien, FRA-Aktien, ETR-Aktien, EPA-Bestände, TSX-Aktien oder Amex Aktien. Sie suchen nach detaillierteren Informationen wie 5g Vorräte, Biotech-Aktien, Goldvorräte und andere Informationen aus unserem Reportlab.
How can you buy DexCom stock on the internet?
You can easily buy DexCom stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Eine weitere Option ist die Nutzung eines regulierten Brokers wie IC-Märkte oder Interaktive Makler. You can an account with these brokers and start buying or trading NASDAQ:DXCM stocks in a safe and complete environment to trade in.
Where to buy DexCom stock?
You will first want to find a licensed broker that supports NASDAQ:DXCM stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:DXCM stocks in a safe and complete environment.
Is NASDAQ:DXCM stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:DXCM stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is DexCom stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:DXCM is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in DexCom stock.
How do you trade DexCom stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for DexCom stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:DXCM stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell DexCom stock?
To sell your NASDAQ:DXCM stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best DexCom stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:DXCM stock.
Stephen kennt sich gut mit Finanzprodukten aus und hat insbesondere eine große Leidenschaft für die Aktienmärkte und ihre Teilnehmer. Wir hoffen, dass die bereitgestellten Informationen Ihnen helfen werden. Ist Ihnen etwas nicht ganz klar? Bitte hinterlassen Sie Ihre Fragen oder Kommentare unten auf der Seite.
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ |
Newsletter
Neueste Nachrichten
| |
Unser Ergebnis |
0% Kommission |
Top 10 5G Aktien Mehr Informationen 5G Aktien Top 10 Beste 5G Aktien zum Kaufen
Aktien & Krypto-Daten in Echtzeit
Benachrichtigungen, Tipps & Neuigkeiten
Beste Aktien & Krypto-Führer
Online Broker & Börse Bewertungen
Reportlab Finanzen ist eine rein informative Website und stellt in keinem Fall eine Anlageberatung dar. Alle Investitionen sind mit Risiken verbunden und Sie können Ihre gesamten Investitionen verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren.
Reportlab Finanzen
38 Holburn Lane
Heckfield Green
IP21 0UB
Vereinigtes Königreich
Copyright © 2022 Reportlab.Finance | Alle Rechte vorbehalten.
